Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1635 of 6351
-
Diet or drugs? new study tests if fasting beats pills for fatty liver disease
Disease control By invitation onlyIn the Netherlands, there are many people with cardiometabolic diseases. More than half of these people also have fatty liver. This is a build-up of fat in the liver (steatosis) and can lead to long-term scarring (fibrosis) and even death of the liver. Losing weight can help redu…
Phase 4 • Sponsor: Carmen Dietvorst • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New cancer drug ABBV-324 enters first human trials
Disease control Recruiting nowHCC is a common cancer worldwide and a leading cause of cancer-related death. Lung cancer is the most frequently diagnosed cancer in the world, and the leading cause of cancer deaths. The purpose of this study is to assess adverse events and change in disease activity when ABBV-3…
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New scan technique could predict stroke by spotting dangerous plaque
Diagnosis Recruiting nowCarotid atherosclerotic plaque rupture is the main cause of ischemic stroke attacks, and early and precise assessment of plaque vulnerability can prevent ischemic stroke. High-resolution MRI can reflect vulnerable plaque features such as thin fibrous caps and large lipid cores, b…
Sponsor: Ruijin Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
AI-Powered coaching: could tailored texts boost weight loss?
Disease control CompletedThe purpose of this pilot study is to conduct a 12-week pilot feasibility study testing usability of a reinforcement learning model (AdaptRL) in a weight loss intervention (ADAPT study). Building upon a previous just-in-time adaptive intervention (JITAI), a reinforcement learning…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New drug combo aims to tame rare histiocytosis in adults
Disease control Recruiting nowTreatment of Adult Patients with Newly Diagnosed Langerhans Cell Histiocytosis (LCH) Using a Low-Dose Cytarabine Combined with Thalidomide Regimen.
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New hope for COPD sufferers: drug targets high eosinophils to cut Flare-Ups
Disease control CompletedThe purpose of this study is to investigate lung function parameters, composite endpoint for exacerbations in chronic obstructive pulmonary disease (COPDCompEx), symptoms and to provide safety information after tozorakimab or placebo administrations in participants with symptomat…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New glasses film aims to stop kids' eyesight from getting worse
Disease control OngoingThe goal of this clinical trial is to learn if spectacle films using Active Reconfiguration in Retinal Encoding of Spatio-Temporal (A.R.R.E.S.T.®) signal technology works to slow down the rate of myopia progression in myopic children. The first stage of the trial compares spectac…
Sponsor: nthalmic Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Digital program aims to curb diabetes risk in hispanic youth
Prevention Recruiting nowHispanic adolescents are disproportionately burdened by type 2 diabetes (T2D). Social determinants of health (SDoH) serve as barriers to behavior change and participation in disease prevention efforts, especially among vulnerable adolescents. Telehealth is a potentially effective…
Sponsor: Baylor College of Medicine • Aim: Prevention
Last updated Jul 09, 2026 00:00 UTC
-
New drug combo aims to tame psoriatic arthritis pain
Disease control Recruiting nowPsoriatic arthritis (PsA) is a type of arthritis that happens when the body's immune system attacks healthy cells and tissues causing joint pain, stiffness, and swelling. Symptoms can get worse and go away for periods of time. This study will evaluate the efficacy and safety of t…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could ozempic help control diabetes in spinal cord injury patients?
Disease control Recruiting nowIt is not known whether a new diabetes drug, semaglutide, is an effective treatment for type 2 diabetes for persons with spinal cord injury (SCI), a population at higher risk for this condition. Therefore, this study looks at the effect of semaglutide on glucose levels in the bod…
Phase 4 • Sponsor: Marzieh Salehi • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New gene therapy combo tackles aggressive lymphoma in early trial
Disease control Recruiting nowThis is an exploratory, open-label, investigator-initiated trial (IIT) of the safety, efficacy, and PK/Pd of UB-VV400 alone and in combination with rapamycin in adult subjects with R/R LBCL. LBCL will include subjects with aggressive lymphoma, defined as diffuse large B-cell lymp…
Phase 1 • Sponsor: Nanjing IASO Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 17:45 UTC
-
New combo pill aims to simplify diabetes care from day one
Disease control Recruiting nowThis multicenter, randomized controlled trial aims to evaluate the efficacy and safety of Henagliflozin-Metformin Sustained-Release Tablets (I) versus Metformin Tablets in newly diagnosed type 2 diabetes mellitus (T2DM). A total of 268 participants will be randomized (1:1) into t…
Phase 4 • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:41 UTC
-
New combo therapy aims to fight tough pancreatic cancer
Disease control Recruiting nowThis trial is the cohort C part of a multicenter, open label Phase Ib/II clinical study evaluating the preliminary efficacy, safety, and tolerability of LM-108 combined with anti-tumor therapy in patients with advanced solid tumors. The dose of LM-108 combined with penpulimab, al…
Phase 1/2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New immune cell therapy targets Hard-to-Treat leukemia in early trial
Disease control Stopped earlyThis is a phase 1, open-label study to evaluate the safety and efficacy of CD19 t-haNK in patients with B-cell acute lymphoblastic leukemia. Up to 10 patients will receive at least 1 dose of study drug.
Phase 1 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Simple Face-Down position could save lives in breathing failure
Disease control Recruiting nowProne positioning has shown beneficial effects in intubated patients with severe respiratory failure and positive effects in awake patients with COVID-19 pneumonia. Conclusive evidence for patients with AHRF without COVID-19 is still missing. The investigators hypothesis that awa…
Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Brain wave matching may unlock pain relief for drug-resistant patients
Symptom relief Recruiting nowNeuropathic pain is a public health problem with less than 50% of patients being relieved by drug treatments. Surgically implanted motor cortex stimulation represents an invasive therapeutic solution capable of relieving a significant proportion of drug-resistant patients (1 in …
Sponsor: Hospices Civils de Lyon • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Can a smartphone app help children beat insomnia?
Symptom relief Recruiting nowThe proposed pilot will examine feasibility, acceptability, and preliminary efficacy of a digital CBT-I tailored for school-aged children.
Sponsor: University of South Florida • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Breathe away your shyness: online breathwork therapy targets social anxiety
Symptom relief Recruiting nowThis study aims to investigate the potential of supplementing psychotherapy with breathing techniques as a new online therapeutic approach to reduce social anxiety (SA). Clinically significant SA affects a substantial portion of the population (about 13%) and is associated with s…
Sponsor: Maastricht University • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Vital signs alert could save lives in blood cancer care
Disease control Recruiting nowPatients with hematologic malignancies requiring intensive chemotherapy are at risk for life-threatening complications. Organ failure may appear rapidly and delay in initiating life-sustaining interventions may result in increased mortality. This encourages great alertness althou…
Sponsor: University Hospital, Angers • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Which catheter is safer for opening blocked heart arteries? a Head-to-Head test
Disease control CompletedThe goal of this clinical trial is to compare two guiding catheters in patients with coronary artery disease during a percutaneous coronary intervention between Guidex® Guiding catheter (DEMAX) and Launcher™ coronary guide catheters (Medtronic). The main question\[s\] it aims to …
Sponsor: Tianjin Demax Medical Technology Co., Ltd • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC